← SynDRA
S-3304
SynDRA canonical compound SYN0002392 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | MMP2 | MMP9 |
|---|
| Mechanism of action | matrix metalloprotease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- matrix metalloprotease inhibitor
Drug classes
- Matrix Metalloproteinase Inhibitors
Cross-references
Synonyms
- S 3304
- BPHA
- BPHA, Shionogi
- MMP inhibitors, Shionogi
- Matrix metalloproteinase inhibitor, Shionogi
- BK459F050X
- s3304
- S3304 cpd
- RefChem:180607
- MMP Inhibitor S-3304
- DTXCID9096783
- ((5-(p-tolylethynyl)thiophen-2-yl)sulfonyl)-D-tryptophan
- UNII-BK459F050X
- MFCD22200275
- orb1307710
- orb1739428
- SCHEMBL2380826
- SCHEMBL29396360
- YWCLDDLVLSQGSZ-JOCHJYFZSA-N
- GLXC-26541
- S 3304 [WHO-DD]
- BDBM50063129
- AKOS030593350
- DS-19841
- HY-106992
- CS-0027075
- NS00068313
- C73841
- T16966
- F862118
- S 3304?
Look up S-3304 in the interactive SynDRA portal →